Literature DB >> 9153519

Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

A E Baird1, A Benfield, G Schlaug, B Siewert, K O Lövblad, R R Edelman, S Warach.   

Abstract

We aimed to determine the frequency and time course of the enlargement of ischemic cerebral lesions following human stroke and to study the effect of the state of perfusion on lesion enlargement. Acute lesion volumes were measured on diffusion-weighted magnetic resonance images and compared with lesion volumes measured on T2-weighted images at 7 days or later. Forty-four measurements were performed between 2 and 53 hours after stroke onset in 28 patients. Thirteen patients also had magnetic resonance perfusion imaging performed. In 12 (43%) of 28 patients the initial lesion volume increased by 20% or more. The number of studies showing enlargement of the ischemic lesion volume ranged from 12 (43%) of 28 at or after 2 hours to 10 (38%) of 26 at or after 6 hours, 5 (33%) of 15 at or after 24 hours, and 2 (33%) of 6 at or after 48 hours. In 7 of the 10 patients in whom the hypoperfusion volume acutely exceeded the volume of the abnormality on diffusion-weighted images, lesion volume increased by 20% or more. This study provided evidence that substantial enlargement of human cerebral ischemic lesion volumes can occur beyond the first 6, 12, or 24 hours after onset. A mismatch acutely between the region of hypoperfusion (larger) and the region of diffusion abnormality (smaller) may be predictive of ischemic lesion enlargement.

Entities:  

Mesh:

Year:  1997        PMID: 9153519     DOI: 10.1002/ana.410410506

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  100 in total

1.  Acute Ischemic Stroke.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

2.  Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging.

Authors:  Qiang Shen; Marc Fisher; Christopher H Sotak; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2004-03       Impact factor: 6.200

Review 3.  Cerebral microinfarcts: the invisible lesions.

Authors:  Eric E Smith; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

4.  Defining the ischemic penumbra using hyperacute neuroimaging: deriving quantitative ischemic thresholds.

Authors:  Andria L Ford; Hongyu An; Katie D Vo; Weili Lin; Jin-Moo Lee
Journal:  Transl Stroke Res       Date:  2012-05-01       Impact factor: 6.829

5.  DIDS protects against neuronal injury by blocking Toll-like receptor 2 activated-mechanisms.

Authors:  Hang Yao; Hady Felfly; Juan Wang; Dan Zhou; Gabriel G Haddad
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

6.  Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory.

Authors:  O Y Bang; P H Lee; K G Heo; U S Joo; S R Yoon; S Y Kim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

7.  Impact of an immune modulator fingolimod on acute ischemic stroke.

Authors:  Ying Fu; Ningnannan Zhang; Li Ren; Yaping Yan; Na Sun; Yu-Jing Li; Wei Han; Rong Xue; Qiang Liu; Junwei Hao; Chunshui Yu; Fu-Dong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Diffusion-weighted MR imaging in the early diagnosis of periventricular leukomalacia.

Authors:  Alessandro Bozzao; Ambrogio Di Paolo; Clarissa Mazzoleni; Fabrizio Fasoli; Alessandra Simonetti; Luigi Maria Fantozzi; Roberto Floris
Journal:  Eur Radiol       Date:  2003-02-07       Impact factor: 5.315

Review 9.  Computed tomography in acute ischemic stroke.

Authors:  Karl-Olof Lövblad; Alison E Baird
Journal:  Neuroradiology       Date:  2009-12-02       Impact factor: 2.804

Review 10.  Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.

Authors:  Tracy D Farr; Susanne Wegener
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.